Explore chapters and articles related to this topic
The Pharmacist-Patient Relationship
Published in Harvey M. Rappaport, Kelly S. Straker, Tracy S. Hunter, Joseph F. Roy, The Guidebook for Patient Counseling, 2020
Harvey M. Rappaport, Kelly S. Straker, Tracy S. Hunter, Joseph F. Roy
Pharmaceutical care has been defined as “the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve the patient’s quality of life.” The possible outcomes include: (1) cure a disease, (2) eliminate or reduce the patient’s symptoms, (3) arrest or slow a disease’s progress, and (4) prevent a disease or symptoms of a disease. Thus, under pharmaceutical care as well, the pharmacist provides pharmaceutical expertise in exchange for a patient’s medication compliance.
Pharmaceutical Care
Published in William N. Kelly, Pharmacy, 2018
The initial definition of pharmaceutical care by Hepler and Strand was “the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life.”12,13 In 1993, out of concern that the original definition meant that pharmaceutical care could be delivered by anyone and fear that other health care practitioners would misinterpret this to mean that pharmacists would practice independently, the ASHP drafted a new definition for pharmaceutical care: Pharmaceutical care is defined as the functions performed by a pharmacist in: Ensuring the optimal use of medications to achieve specific outcomes that improve a patient's quality of life; further, the pharmacist accepts responsibility for outcomes that ensue from his or her actions, which occur in collaboration with patients and other healthcare colleagues.15
The development and evaluation of a clinical pharmacy course at a pharmacy school in Indonesia
Published in Elida Zairina, Junaidi Khotib, Chrismawan Ardianto, Syed Azhar Syed Sulaiman, Charles D. Sands, Timothy E. Welty, Unity in Diversity and the Standardisation of Clinical Pharmacy Services, 2017
F. Rahmawati, D. Wahyono, M. Ihsan
Currently, most of colleges of pharmacy in the world have already implemented curricula according to the concept and philosophy of pharmaceutical care (Anonymous 1993). Pharmaceutical care involves the use of a treatment plan for the purpose of achieving patient-specific outcomes that will improve quality of life. In order achieve such competency, the pharmacist have to obtain skills to identify patient-specific information, integrate it with pharmacotherapy knowledge and make a decision on the most appropriate drug therapy for the patient.
Analysis of prescribing error and pharmacist’s intervention on obstetrics and gynaecology outpatient prescriptions in a Malaysian tertiary hospital
Published in Journal of Obstetrics and Gynaecology, 2022
Jeevanandan Narayanan, Shamala Balan, Ong Li Ling, Nurhamizah Kasim, Prcella Johny
Prescription screening poses direct impact in providing safe and appropriate drug therapy. Most pharmacist assumes the professional responsibility of screening prescription to optimise treatment outcome and reduce harm to patient (American Pharmacists Association 2016; Dalton and Byrne 2017). Data obtained from this study concurred with the statement above whereby most of the pharmacist interventions (54.2%) were conducted with the rationale of optimising treatment outcome. The majority of pharmacist interventions performed in this study were classified as ‘very significant’ in relation to its clinical significance. Similar findings were also observed in previous studies (Ferracini et al. 2018; Silva et al. 2018). Assessment of the clinical significance of pharmacists’ interventions at an outpatient setting emphasises the need for the implementation of pharmaceutical care structure in outpatient setting (Pereira et al. 2022). In addition, all interventions made by pharmacist in this study were well received and accepted by the prescriber. This shows that pharmacist and prescriber collaborate as an effective healthcare team to provide best patient-centred pharmaceutical care.
Rational drug use in hospital settings – areas that can be changed
Published in Journal of Medical Economics, 2020
Urszula Religioni, Teresa Pakulska
In optimizing the drug economy, the role of pharmacists should be especially emphasized. Pharmaceutical care comprises three main elements:detecting actual or potential drug problems,solving real drug problems, andprevention of drug problems,where a medication-related problem is considered as any adverse experience of the patient caused by a drug that affects the effects of therapy. The American Society of Health-System Pharmacists (ASHP) indicates that the most common drug problems are: inadequate drug selection, inadequate dosage, no use of the drug when it is necessary, too long use of the drug, side-effects associated with drug therapy, and drug interactions6.
Creating and evaluating an opportunity for medication reconciliation in the adult population of South Africa to improve patient care
Published in Hospital Practice, 2018
Pranusha Naicker, Natalie Schellack, Brian Godman, Elmien Bronkhorst
Medication reconciliation: This is a process of systematically identifying the medications a patient is currently taking in their home and comparing them with newly ordered medications in the hospital [20].Medication error: Any preventable event that occurs during any stage of the medication use process that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional, patient or consumer [41,42]. Furthermore, it can also be defined as ‘Any preventable events that may cause or lead to inappropriate medication use or patient harm’.Pharmaceutical care: The responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient’s quality of life [43]. It is further stated that it is based on a relationship between the patient and the healthcare providers, who accept responsibility to provide care to the patients, and involves the active participation of both the patient and the healthcare provider in drug therapy decisions [44].